What is the difference between a clinical trial and an expanded access program?

raymond.vanderwaal@mytomorrows.com 11 Jan 2024

1 mins read

share this post

The main difference between a clinical trial and an expanded access program is that the intention of a clinical trial is to conduct research to test safety and efficacy of a new drug, while the intention of an expanded access program is for a physician to provide treatment to their patient with an unmet medical need. Both clinical trials and expanded access programs have eligibility criteria to determine who can participate.   

However, the criteria of expanded access programs usually allow for a broader group of patients. This means that a patient who is not eligible for a clinical trial might be able to access a new drug via an expanded access program. Patients who enroll in expanded access programs are often the sickest patients who have exhausted other treatment options. 

share this post

raymond.vanderwaal@mytomorrows.com 11 Jan 2024

more articles

view all blogs
myTomorrows Trust Center blog

myTomorrows Trust Center: Security, Compliance, and Transparency

Filippo Mandrini

19 Feb 2026

9 mins read

Man with ALS performing physical therapy
ALS
Neurological disorders
Physical Therapy

The Role of Physical Therapy in ALS Care

Andrea Enguita

14 Jan 2026

16 mins read

Medical researchers
Rare Disease
MAP

Sentynl Selects myTomorrows to Lead Managed Access Program

myTomorrows Team

15 Dec 2025

4 mins read

Oncology
Clinical Trials
HCPs
Trial sites

Whitepaper: Advancing Neuro-Oncology Clinical Trial Access

Daniël Groeneweg

27 Nov 2025

8 mins read

Person with end-stage Parkinson's and caregiver
Neurological disorders
Parkinson's disease
End-stage Parkinson's

End-Stage Parkinson’s Disease: Symptoms, Care, and Support

Andrea Enguita

18 Nov 2025

21 mins read

Referrals
Clinical researchers
Trial sites
Clinical Trials

Getting Started: myTomorrows Referral Platform for Site Staff

Adrianne Rivard

14 Nov 2025

10 mins read

myTomorrows Avego finding announcement
Investment
Funding
Patient Access

Our next chapter: €25M growth investment to scale patient access worldwide

Michel van Harten

11 Nov 2025

7 mins read

ALS patient flow
Expanded Access Programs
BioPharma
ALS Clinical Trials

Accelerating ALS Clinical Trial Recruitment in the U.S.

Dennis Akkaya

10 Oct 2025

12 mins read

Vanessa Lemarie
Tech
Award
Innovation

myTomorrows’ COO Vanessa Lemarié Named in Sifted’s Top 100 Women in Tech Europe

Michel van Harten

10 Oct 2025

2 mins read

Clinical Trials
Trial sites
Clinical researchers
Referrals

Smarter Clinical Trial Recruitment that Delivers Faster Site Enrollment

Dennis Akkaya

18 Sep 2025

10 mins read